Croissance Drugs Private Limited

Founded in 2014 and headquartered in Maharashtra, India.

2014 | Nagpur, Maharashtra (India) | Inactive
Last Updated: March 31, 2024

Croissance Drugs Profile

Key Indicators

  • Authorised Capital ₹ 0.50 M
  • Paid Up Capital ₹ 0.15 M
  • Company Age 11 Year, 3 Days

About Croissance Drugs

Croissance Drugs Private Limited (CDPL) is Strike Off company established on 28 Jan 2014 with its office registered at Nagpur, Maharashtra, India and has been running since 11 Year, 3 Days with a paid up capital of 0.15 M. According to MCA records, 4 Directors are linked to this company as of 31 Mar 2024.

Company Details

  • Location

    Nagpur, Maharashtra, India

  • Telephone

    +91-XXXXXXXXXX

  • Email Address
  • Website

    -

  • Social Media
    -

Corporate Identity Details

  • CIN/LLPIN

    U24100MH2014PTC252512

  • Company No.

    252512

  • Company Classification

    Private Limited Indian Non-Government Company

  • Incorporation Date

    28 Jan 2014

  • Date of AGM

    -

  • Date of Balance Sheet

    -

  • Listing Status

    Unlisted

  • ROC Code

    Roc Mumbai

Industry

Chemicals

Who are the key members and board of directors at Croissance Drugs?

Board Members (4)

NameDesignationAppointment DateStatus
Meenakshi Shinde Country flag representing In Director 28-Jan-2014Current
Chaitali Wankhede Country flag representing In Director 09-Oct-2015Current
Chanderlal Jhambia Country flag representing In Director 28-Oct-2015Current
Vishal Jhambia Country flag representing In Director 28-Oct-2015Current

Financial Performance of Croissance Drugs.

Enhance accessibility to Croissance Drugs's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.

Graph illustrating revenue growth over time
Graph showing profit and loss trends over time
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023)YOY Growth
(FY 2022)(FY 2021)(FY 2020)(FY 2019)
Total Revenue
Revenue from Operations
Total Assets
Profit or Loss
Net Worth
EBITDA

What is the Ownership and Shareholding Structure of Croissance Drugs?

Unlock access to Croissance Drugs's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.

Shareholding Indicator graph

Charges (Loans)

Placeholder for charges-related data

There are no open charges registered against the company as per our records.

How Many Employees Work at Croissance Drugs?

Unlock and access historical data on people associated with Croissance Drugs, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Graph showing employee growth trends

Deals i

Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Croissance Drugs, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Croissance Drugs's trajectory.

Rating

Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts

Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Latest Updates, News, and FAQs on Croissance Drugs

Recent activity within the organization

  • Director Appointment

    Chanderlal Diwanmal Jhambia was appointed as a Director was appointed as a Director on 28 Oct 2015 & has been associated with this company since 9 years 3 months .

    28 Oct 2015

  • Director Appointment

    Vishal Chanderlal Jhambia was appointed as a Director was appointed as a Director on 28 Oct 2015 & has been associated with this company since 9 years 3 months .

    28 Oct 2015

  • Director Appointment

    Chaitali Gantgadhar Wankhede was appointed as a Director was appointed as a Director on 09 Oct 2015 & has been associated with this company since 9 years 3 months .

    09 Oct 2015

  • Director Appointment

    Meenakshi Ajay Shinde was appointed as a Director was appointed as a Director on 28 Jan 2014 & has been associated with this company since 11 years 3 days .

    28 Jan 2014

  • Company Incorporation

    Croissance Drugs Private Limited was registered on 28 Jan 2014 with Roc Mumbai & aged 11 years 3 days as per MCA records.

    28 Jan 2014

Frequently asked questions

  • Croissance Drugs Private Limited was incorporated on 28 Jan 2014.

  • The authorized share capital of Croissance Drugs Private Limited is ₹ 0.50 M and paid-up capital is ₹ 0.15 M.

  • Currently 4 directors are associated with Croissance Drugs Private Limited.

    • Meenakshi Ajay Shinde
    • Chaitali Gantgadhar Wankhede
    • Chanderlal Diwanmal Jhambia
    • Vishal Chanderlal Jhambia
  • As per Ministry of Corporate Affairs (Mca), the registered address of Croissance Drugs Private Limited is Shop No 4 Second Floor, B R Complex Tawakkal Layout Wadi, Nagpur, Maharashtra, India, 440023.

  • The corporate identification number (CIN) of Croissance Drugs Private Limited is U24100MH2014PTC252512 and the company number is 252512 as per Ministry of Corporate Affairs (MCA).

People also Viewed

Similar Companies Based on Manufacturing